Drug maker Lupin on Thursday said it will acquire two inhalation brands from Sunovion Pharmaceuticals Inc for USD 75 million (around Rs 622 crore).The drug firm has inked a pact
Share this article
If you liked this article share it with your friends.they will thank you later